How to handle unexpected biological abnormalities observed in the pre-donation workup for hematopoietic stem cell transplantation: An SFGM-TC report on pre-transplant cytomegalovirus, Epstein-Barr virus, Toxoplasma gondii, or syphilis IgM positive serology test | Conduite à tenir devant une anomalie biologique découverte lors du bilan pré-don cellules souches hématopoïétiques : sérologie IgM positive pour le cytomégalovirus, le virus d’Epstein-Barr, la toxoplasmose, ou la syphilis
2013
Duléry, R. | Giraud, C. | Beaumont, J.-L. | Bilger, K. | Borel, C. | Dhedin, N. | Thiebaut, A. | Willems, E. | Alain, S. | Alfandari, S. | Dewilde, A. | Jouet, J.-P. | Milpied, N. | Yakoub-Agha, I.
In the attempt to harmonize clinical practices between different French transplantation centers, the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC) set up the third annual series of workshops which brought together practitioners from all member centers and took place in October 2012 in Lille. Here we report our results and recommendations regarding the management of pre-transplant donor's cytomegalovirus, Epstein-Barr virus, Toxoplasma gondii, or syphilis IgM positive serology test.
显示更多 [+] 显示较少 [-]